Premesis Syrup is an anti-emetic medicine made by Globe Pharmaceuticals Ltd. It comes as a syrup with a strength of 4 mg/5 ml and is supplied in a 50 ml bottle. It contains the generic ondansetron.
There are 74 brands of Ondansetron listed in Bangladesh. 35 of them have a lower unit price than Premesis. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Premesis 4 mg/5 ml Syrup?
Premesis Syrup is a liquid anti-emetic medicine containing the generic ondansetron. It is made by Globe Pharmaceuticals Ltd. and supplied as a 4 mg/5 ml syrup in a 50 ml bottle. Ondansetron works by blocking a serotonin receptor in the body that is involved in triggering the vomiting reflex. Doctors use it to help control nausea and vomiting linked to certain cancer chemotherapy, radiotherapy and surgery. It does not treat the underlying cause of vomiting. The doctor decides whether it is suitable, the dose and the length of the course.
Uses of Premesis
Premesis Syrup is used to prevent nausea and vomiting caused by emetogenic cancer chemotherapy, including initial and repeat courses. It is also used to prevent and treat nausea and vomiting after surgery, and to prevent nausea and vomiting caused by radiotherapy. It belongs to a group of medicines called anti-emetics. It helps control the symptom of vomiting but does not treat the condition causing it. Ask the doctor if you are unsure why it has been prescribed.
How to use Premesis
Give or take Premesis Syrup as the doctor tells you. The doctor decides the dose and how long the course should last, based on the reason it is being used and the person's needs. Do not change the amount or stop early without advice. If a dose is missed, ask the doctor or pharmacist what to do rather than guessing. Store the bottle at a temperature not exceeding 30°C in a dry place, and protect it from light and moisture.
Side effects of Premesis
Common side effects include headache, constipation and diarrhoea, and most of these are mild or moderate. Rash has been reported in some patients receiving ondansetron for chemotherapy-induced nausea and vomiting. Some people have reported a feeling of flushing or warmth, hiccups and changes in liver enzymes. Rare reports include allergic reactions, wheezing, fast heartbeat, chest pain, low potassium and shortness of breath. Tell the doctor if you notice any side effect that worries you.
Safety and precautions
Do not use Premesis Syrup if there is a known allergy to ondansetron or any ingredient, or with apomorphine. Tell the doctor about allergies to other similar anti-emetic medicines. It is not a medicine that speeds up gut movement and should not replace nasogastric suction. After abdominal surgery or during chemotherapy, it may hide a developing ileus or stomach bloating, so the doctor should be told about such symptoms. There are no adequate, well-controlled studies in pregnancy, so ask the doctor before use, especially if pregnant, planning pregnancy or breastfeeding.
Frequently asked questions
What does the generic name ondansetron mean?
Ondansetron is the generic name of the active ingredient in Premesis Syrup. It is the same medicine used in other brands, and the generic name helps you and your pharmacist identify the medicine regardless of the brand. The brand name is Premesis and it is made by Globe Pharmaceuticals Ltd.
What is Premesis Syrup used for and what kind of medicine is it?
It is an anti-emetic medicine used to prevent nausea and vomiting from certain cancer chemotherapy, radiotherapy and surgery. It contains ondansetron, which blocks a serotonin receptor involved in the vomiting reflex. The doctor decides if it is suitable and how it should be used.
Which medicines may interact with Premesis Syrup?
Ondansetron is broken down by liver enzymes, so medicines that affect these enzymes may change how long it stays in the body. It should not be used with apomorphine. Tell the doctor or pharmacist about all medicines, including herbal products, that you or the patient are taking.
What is the price of Premesis Syrup?
The listed price is ৳ 44.00. Ask the pharmacist for the current price and availability. The doctor decides the dose and course; do not change how it is used based on price or pack size.
Ondansetron is a serotonin subtype 3 (5-HT3) receptor antagonist indicated:
Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
Prevention and treatment of post-operative nausea and vomiting.
Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Ondansetron is a potent, highly selective 5HT3 receptor-antagonist. Its precise mode of action in the control of nausea and vomiting is not known. Chemotherapeutic agents and radiotherapy may cause release of 5HT in the small intestine initiating a vomiting reflex by activating vagal afferents via 5HT3 receptors. Ondansetron blocks the initiation of this reflex. Activation of vagal afferents may also cause a release of 5HT in the area postrema, located on the floor of the fourth ventricle, and this may also promote emesis through a central mechanism. Thus, the effect of ondansetron in the management of the nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy is probably due to antagonism of 5HT3 receptors on neurons located both in the peripheral and central nervous system. The mechanisms of action in post-operative nausea and vomiting are not known but there may be common pathways with cytotoxic induced nausea and vomiting.
Dosage & Administration
Chemotherapy-Induced Nausea and Vomiting- Adults, Pediatric patients (6 months to 18 years):
8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Radiotherapy-Induced Nausea and Vomiting- Adults:
8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Postoperative Nausea and Vomiting- Adults:
8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
Chemotherapy-induced Nausea and Vomiting- Adults/Geriatric/Child of 12 years or over:
Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Pediatric (4-11 years): 5 ml (4 mg) Ondansetron Oral Solution should be taken 30 minutes before the start of chemotherapy. The other 2 doses should be taken 4 and 8 hours after the first dose. Then 5 ml oral solution should be administered 3 times a day (every 8 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
Postoperative Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:
Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy:
Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Ondansetron does not itself appear to induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system of the liver. Because Ondansetron is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes, inducers or inhibitors of these enzymes may change the clearance and hence, the half-life of Ondansetron. On the basis of available data, no dosage adjustment of Ondasetron is recommended for patients on these drugs.
Contraindications
Contraindicated in patients known to have hypersensitivity to the drug or any of its components. Concomitant use of apomorphine.
Side Effects
Frequently reported adverse events were headache, constipation and diarrhea, but the majority have been mild or moderate in nature. In chemotherapy-induced nausea and vomiting, rash has occurred in approximately 1% of patients receiving Ondansetron. There also have been reports to a sensation of flushing or warmth, hiccups and liver enzyme abnormalities. Rare cases of anaphylaxis, brochospasm, tachycardia, angina (chest pain), hypokalemia, shortness of breath have also been reported, except for bronchospasm and anaphylaxis, the relationship to Ondansetron is unclear. There have been no evidence to extrapyramidal reactions, in rare case oculogyric crisis appearing alone, as well as with other dystonic reactions without definitive clinical evidence. In case of PONV, with the exception of headache, rates of these events were not significantly different in the Ondansetron and placebo groups.
Pregnancy & Lactation
Carcinogenic effects were not seen in 2-year studies in rats and mice with oral Ondansetron doses up to 10 and 30 mg/kg per day, respectively. Ondansetron was not mutagenic in standard tests for mutagenicity. Oral administration of Ondansetron up to 15 mg/kg per day did not affect fertility or general reproduction performance of male and female rats.
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Hypersensitivity reactions have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists. Ondansetron is not a drug that stimulates gastric or intestinal peristalsis. It should not be used instead of nasogastric suction. The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension.
Storage Conditions
Store at temperature not exceeding 30ºC in a dry place. Protect from light and moisture.
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.